Trial intelligence / Profile preview

Evered: Everolimus vs MMF in ECD/DCD Kidney Transplant

NCT01878786Phase 3Terminated

Start
Jun 2013
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of everolimus in kidney transplantation. Started Jun 2013; status: terminated.

02

Drugs

everolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT01878786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01878786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call